These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8026311)

  • 21. [Chronic hepatitis: current diagnostics and treatment in different etiologic factors].
    Glaumann H; Lööf L; Weiland O
    Lakartidningen; 1991 Mar; 88(13):1201-4. PubMed ID: 1901930
    [No Abstract]   [Full Text] [Related]  

  • 22. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy.
    Deutsch M; Dourakis S; Manesis EK; Gioustozi A; Hess G; Horsch A; Hadziyannis S
    Hepatology; 1997 Jul; 26(1):206-10. PubMed ID: 9214471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [What treatment for chronic viral hepatitis?].
    Dal Monte PR; Giuliani Piccari G
    G Clin Med; 1988; 69(8-9):541-5. PubMed ID: 2462521
    [No Abstract]   [Full Text] [Related]  

  • 24. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
    Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis.
    Dumoulin FL; Leifeld L; Sauerbruch T; Spengler U
    Biomed Pharmacother; 1999 Jun; 53(5-6):242-54. PubMed ID: 10424246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukocyte and platelet lowering by some interferon types during viral hepatitis treatment.
    Toccaceli F; Rosati S; Scuderi M; Iacomi F; Picconi R; Laghi V
    Hepatogastroenterology; 1998; 45(23):1748-52. PubMed ID: 9840140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
    Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
    Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical immunological features and interferon therapy in chronic hepatitis C].
    Pár A; Paál M; Gógl A; Gervain J; Szekeres J; Sipos J; Beró T; Hütter E; Berencsi G; Kádas I
    Orv Hetil; 1995 Jan; 136(1):9-18. PubMed ID: 7845665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone.
    Scotto G; Fazio V; Tantimonaco G
    Ital J Gastroenterol; 1996 Dec; 28(9):505-11. PubMed ID: 9131395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drugs active against hepatitis viruses].
    Goudeau A
    Rev Prat; 1997 Mar; 47(6):640-5. PubMed ID: 9183938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recombinant alfa interferon in the treatment of chronic B and non-A, non-B hepatitis: preliminary results].
    da Silva LC; Carrilho FJ; da Fonseca LE; Farias SM; Faggion P; Granato CF; Vianna MR; Alves VA; Gayotto LC
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):201-6. PubMed ID: 2517713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A controlled study of treatment with recombinant interferon alpha of chronic hepatitis due to the B virus in childhood].
    Carreño V; Porres JC; Ruiz-Moreno M; Gutiez J; Bartolomé FJ
    Rev Esp Enferm Dig; 1991 Jan; 79(1):24-8. PubMed ID: 2031770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Disclosure of autoimmune hepatitis by interferon].
    Payen JL; Rabbia I; Combis M; Voigt JJ; Vinel P; Pascal JP
    Gastroenterol Clin Biol; 1993; 17(5):404-5. PubMed ID: 8349084
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of chronic hepatitis B, delta related liver disease and non-A non-B hepatitis.
    Jafri SM
    J Pak Med Assoc; 1989 Jun; 39(6):162-7. PubMed ID: 2475648
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment with interferon gamma versus interferons alfa and gamma in children with chronic hepatitis B.
    Ruiz-Moreno M; Rúa MJ; Moraleda G; Guardia L; Moreno A; Carreño V
    Pediatrics; 1992 Aug; 90(2 Pt 1):254-8. PubMed ID: 1641292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon may cause retinopathy during hepatitis therapy.
    Shahidullah AB; Cerulli MA; Berman DH
    Am J Gastroenterol; 1995 Sep; 90(9):1543. PubMed ID: 7661198
    [No Abstract]   [Full Text] [Related]  

  • 37. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
    Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
    Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal allograft function in patients with chronic viral hepatitis B and C treated with interferon alpha.
    Durlik M; Gaciong Z; Rancewicz Z; Rowińska D; Wyzgał J; Kozłowska B; Gradowska L; Lao M; Nowaczyk M; Korczak-Kowalska G
    Transplant Proc; 1995 Feb; 27(1):958-9. PubMed ID: 7879245
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hepatitis A, B, C, D, E - What treatment options for whom?].
    Manns M
    Drug Res (Stuttg); 2014 Nov; 64 Suppl 1():S18-9. PubMed ID: 25423421
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferon-alpha for viral hepatitis.
    Jonas MM
    J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):93-106. PubMed ID: 8856573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.